Multiple tumor-suppressor genes on chromosome 3p contribute to head and neck squamous cell carcinoma tumorigenesis

Cancer Biology and Therapy

Volumn 10, Issue 7, 2010, Pages 689-693

  Lee, Dong Jin ^a,b   Schönleben, Frank ^a,c   Banuchi, Victoria E ^a   Qiu, Wanglong ^a   Close, Lanny G ^a   Assaad, Adel M ^a   Su, Gloria H ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Hallym University Medical Center   (South Korea)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

ALS2CL; CAN genes; Chr3p; CMYA1; EPHA3; HNSCC; LOH; Tumor suppressor gene

Indexed keywords

ALS2CL GENE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME 3P; CMYA1 GENE; CONTROLLED STUDY; EPHA3 GENE; HEAD AND NECK CARCINOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MISSENSE MUTATION; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 3; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR PROTEIN-TYROSINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 77957567368     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.7.12886     Document Type: Article

References (17)

1. De Schutter H, Spaepen M, Mc Bride WH, Nuyts S. The clinical relevance of microsatellite alterations in head and neck squamous cell carcinoma: a critical review. Eur J Hum Genet 2007; 15:734-41. (Pubitemid 46969882)
2. Thomas GR, Nadiminti H, Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 2005; 86:347-63.
3. Chung CH, Levy S, Yarbrough WG. Clinical applications of genomics in head and neck cancer. Head Neck 2006; 28:360-8.
4. Perez-Ordonez B, Beauchemin M, Jordan RC. Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 2006; 59:445-53.
5. Reed AL, Califano J, Cairns P, Westra WH, Jones RM, Koch W, et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996; 56:3630-3.
6. Hogg RP, Honorio S, Martinez A, Agathanggelou A, Dallol A, Fullwood P, et al. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma. Eur J Cancer 2002; 38:1585-92.
7. Honjo N, Gunduz M, Fukushima K, Cengiz B, Beder LB, Gunduz E, et al. Comprehensive loss of heterozygosity analysis and identification of a novel hotspot at 3p21 in salivary gland neoplasms. Arch Otolaryngol Head Neck Surg 2007; 137:119-25.
8. Fu L, Qin YR, Xie D, Hu L, Kwong DL, Srivastava G, et al. Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma. Cancer Res 2007; 67:10720-6.
9. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, et al. The consensus coding sequences of human breast and colorectal cancers. Science (New York, NY) 2006; 314:268-74.
10. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321:1801-6.
11. Angeloni D. Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease. Brief Funct Genomic Proteomic 2007; 6:19-39. (Pubitemid 351721045)
12. Wood LD, Calhoun ES, Silliman N, Ptak J, Szabo S, Powell SM, et al. Somatic mutations of GUCY2F, EPHA3 and NTRK3 in human cancers. Hum Mutat 2006; 27:1060-1.
13. Cheng N, Brantley D, Fang W, Liu H, Fanslow W, Cerretti D, et al. Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors. Neoplasia 2003; 5:445-56.
14. Suzuki-Utsunomiya K, Hadano S, Otomo A, Kunita R, Mizumura H, Osuga H, et al. ALS2CL, a novel ALS2-interactor, modulates ALS2-mediated endosome dynamics. Biochem Biophys Res Commun 2007; 354:491-7.
15. van der Ven PF, Ehler E, Vakeel P, Eulitz S, Schenk JA, Milting H, et al. Unusual splicing events result in distinct Xin isoforms that associate differentially with filamin c and Mena/VASP. Exp Cell Res 2006; 312:2154-67.
16. Selivanova G, Wiman KG. Reactivation of mutant p53: molecular mechanisms and therapeutic potential. Oncogene 2007; 26:2243-54. (Pubitemid 46536645)
17. Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics (Oxford, England) 2004; 20:1233-40.